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Three antisera to the C-terminally extended form of gastrin or the C-terminal flanking
peptide of progastrin were used in an attempt to investigate the post-translational
processing of progastrin at the cellular level by light and electron microscopical
immunocytochemistry .
In the normal human gastric antrum, the G-cell secretory granules were found to
contain both gastrin and the C-terminal progastrin determinants (progastrin 87-93, 87-95
and 93-101). Immunostaining of serial sections at the light microscopical level revealed
that duodenal gastrin-containing cells also express the C-terminal progastrin determi-
nants, as well as gastrin-34. In foetal tissue, cells containing C-terminal gastrin and the C-
flanking peptide of progastrin were first seen at 8 weeks of gestation, in the duodenum .
They were not found in the stomach until the 11th week . In hyperplastic G-cells and in
gastrin-producing tumour cells, the level of C-terminal peptide immunoreactivity was
variable and often lower than that seen in normal antrum and only minimal immunoreac-
tivity could be detected using electron immunocytochemistry . This was interpreted as
representing altered post-translational processing of progastrin in modified G-cells .
KEYWORDS : Gastrin, C-terminal peptide of progastrin, immunocytochemistry, electron microscopy,
G-cell hyperplasia, gastrin-producing tumours .
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Most, if not all, bioactive peptides are derived from larger precursor molecules
(prohormones) by proteolytic cleavage at sites characterized by the presence of
dibasic amino acid residues .' Indeed, many prohormones have been found to
contain multiple peptide sequences, limited by potential cleavage sites, a number of
which may effect a biological function, for example pro-opiomelanocortin (POMO
contains the sequences of ACTH, endorphin, (3LPH, MSH and CLIP 2 and pro-
glucagon those of glucagon, glucagon-related pancreatic peptide, glicentin, gluca-
gon-like peptides 1 and 2 . 3-5 As the post-transiational enzymatic cleavage of the
prohormones may be activated differentially by tissue-specific mediators, it is
necessary to determine which sequences are elaborated by each prohormone-
containing endocrine cell type .
Endocrine cells typically contain secretory granules with varied morphology
which is thought to reflect storage of different molecular forms of bioactive peptides
produced during post-translational processing . The mammalian G-cell has been
shown to contain two main granule populations .` We have previously investigated
the processing of gastrin in human G-cells and shown that these two populations, in
fact, correspond to the extremes of the granular maturation process ." Immature,
small electron-dense granules contain both G17 and G34 whilst the intermediate
forms of pale-cored granules have G17 alone. The large, electron-lucent granules
show little or no gastrin immunoreactivity .
More recently, the structure of progastrin has been deduced from the nucleotide
sequence of mRNA cloned from porcine gastric antrum, 10 human gastric antrum"
and human pancreatic gastrin-producing tumours (Zollinger-Ellison syndrome) ."
Human progastrin consists of 101 amino acids, within which is a single copy of
gastrin-34 ('big gastrin', G34 ; Fig . 1) . 12 A nine amino acid sequence (-Gly-Arg-Arg-Ser-
Ala-Glu-Asp-Glu-Asn) flanks G34 at the C-terminal of the precursor. We have used
antisera raised against three synthetic regions of this flanking peptide (see Table 1) in
an immunocytochemical study in order to determine the intracellular localization of
the C-terminal peptide in normal human stomach and duodenum (developing and










Fig. 1 . Diagram of the human progastrin molecule showing the positions of G34, G17 and PSN .
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MATERIALS AND METHODS
Tissues
Specimens of gastric antrum (n = 3), duodenum (n = 5) and pancreatic islet cell
tumours producing gastrin (n=6) were obtained at surgery . Endoscopic biopsy
specimens of gastric antrum from patients with pernicious anaemia (n=10) were
obtained by endoscopy . The stomachs from 25 foetuses (8-28 weeks' gestation)
were collected at legal terminations of pregnancy or from spontaneous abortions .
Light microscopy
Tissues were fixed in Bouin's solution or 10% neutral-buffered formalin, embedded
in paraffin wax and sectioned at 5 gm . For co-localization studies some fixed tissue
was embedded in epoxy resin (see Electron microscopy below) and serially
sectioned at 0 . 5-1 .0 gm .
Light microscopical immunocytochemistry
Immunocytochemical studies were performed using the peroxidase anti-peroxidase
(PAP) technique . 13 Sections were de-waxed in inhibisol or de-resinated in sodium
alkoxide14 and brought to phosphate-buffered saline (PBS, pH 7 . 2) .
Endogenous peroxidatic activity and non-specific staining were blocked by
incubation for 30 min in 0 .3% hydrogen peroxide in PBS followed by a further
10 min in normal goat serum (1 :30 dilution in PBS) .
The primary antisera were applied for 16-24 h at 4 ° C in a moist atmosphere . Full
details of the primary antisera are given in Tables 1 and 2. After thorough rinsing in
PBS, a second layer, goat anti-rabbit IgG antiserum (Miles Labs, Stoke Poges, UK) was
applied for 30 min at 1 :200. Following further rinses in PBS, the sections were
incubated with rabbit PAP complex (Miles Labs) for 30 min at 1 :400 dilution .
Localization of the PAP complex was achieved using a solution of 3,3'-diaminoben-
zidine tetrahydrochloride (0025%) and hydrogen peroxide 0-01% in PBS for 5-
8 min. After development of the reaction product the sections were dehydrated
through graded ethanols to xylene, mounted in DPX and examined with a
transmitted light microscope .
Electron microscopy
Specimens of each tissue were fixed in 2 .5-3 .0% glutaraldehyde in 0 . 1 M sodium
phosphate buffer pH 7 .2 for 2-4 h. After rinsing in 0 . 1 M sodium phosphate buffer
pH 7 .2 containing 0 . 1 M sucrose half of the blocks were osmicated (1 % osmium
tetroxide in Millonig's phosphate . buffer, pH 7 . 2 for 1 h) . The samples were then
rinsed in buffer, dehydrated through a graded series of ethanols and embedded in
Araldite epoxy resin . Ultra-thin sections, showing silver to silver-grey interference
colours, were mounted on cleaned, uncoated 200- or 300-mesh hexagonal nickel
grids .
NT, not tested .
nmol peptide ml ' diluted antiserum .
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' PAP, light microscopical peroxidase anti-peroxidase
method; IGS, immunoglobulin-gold staining method (electron
microscopy) ; NS, antisera not suitable for ultrastructural locali-
zation .
Electron microscopical immunocytochemistry
A modified immunoglobulin-gold staining procedure was used . 15,16 Briefly, sections
of osmicated tissue were treated with a saturated aqueous solution of sodium
metaperiodate for 30-60 min" to diminish the protein masking effect of osmium .
After rinsing in PBS the grids were incubated in normal goat serum at 1 :20 dilution in
PBS for 30 min followed by primary antiserum for 2-3 h at room temperature, or
overnight at 4°C at optimal titre (Table 2) . The grids were thoroughly washed on
droplets of 50 mmol Tris-HCI buffer, pH 7 . 2, containing 0 . 1 % Tween 20 (3 X 5 min),
50 mmol Tris-HCI buffer, pH 7 . 2, containing 0 .1 % Tween 20 and 0 .2% bovine serum
albumin (BSA, Sigma fraction V, globulin-free; 2 X 5 min) and 50 mmol Tris-HCI
buffer, pH 8 .4, containing 0 .1 % Tween 20 and 1 0/o BSA (1 X 5 min) . This washing step
was followed by incubation in 10 nm gold-labelled goat anti-rabbit IgG (Janssen
Pharmaceutica, Beerse, Belgium) at optimal titre for 30-60 min . Excess gold-labelled
reagents were washed off with 50 mmol Tris-HCI buffer, pH 7 . 2, containing 0 . 1
Tween 20 (6 X 3 min) followed by distilled water (3 X 3 min) . The grids were then
counterstained with methanolic uranyl acetate and aqueous lead citrate before
viewing in a transmission electron microscope .
Specificity controls were performed as in Table 3 .
Table 3 . PSN antiserum absorption test
Peptide used for absorption
Peptide -
concentration PSN PSN-Tyr G17 PSS
20 nmol ml - '* Completely Not absorbed Not absorbed NI
absorbed
10 nmol ml - ' Completely NT NT Not absorbed
absorbed
1 nmol ml - ' Partially absorbed NT NT NT
0 . 1 nmol ml - ' Not absorbed NT NT NT
0 .01 nmol ml- ' Not absorbed NT NT NT
Table 2 . Dilutions of the antisera used
Dilutions*
Code PAP IGS
GL7 1 :1600 NS
GL9 1:800 NS
PSN 1 :1000 1 :5000
PSS 1:500 1 :2000
G17 1 :5000 1 :2500
C34 1 :1600 1 :1000
100
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RESULTS
In this paper, for clarity, each antiserum is referred to by its code, i .e ., antiserum PSN
was raised against the C-terminal flanking nonapeptide of progastrin (progastrin 93-
101; see Table 1 and Fig . 1) ; GL7 against a C-terminal heptapeptide (progastrin 87-
93); GL9 against a C-terminal nonapeptide (progastrin 87-95) . Antiserum PSS was
raised against the C-terminal flanking peptide (96-104, see Table 1) of procholecys-
tokinin (PSS) . However, such a description is not meant to reflect an absolute
specificity for that particular antiserum, but simply to designate the antigen used in
immunization .
The results of the antiserum adsorption tests are given in Table 3 . Immunostaining
with an antiserum to the C-terminal flanking peptide of progastrin (PSN) could be
prevented completely by pre-adsorption with 10 nmol of homologous peptide ml - '
diluted antiserum, whereas the same antiserum was unaffected by 10 nmol ml - ' of
the C-terminal flanking peptide of procholecystokinin (PSS) and 20 nmol ml - ' of
PSN-tyrosine and gastrin-17 . The specificities of antisera GL7 and GL9 are reported
elsewhere .'
Many cells reactive to antisera raised against C-terminal immunoreactants of
human progastrin (PSN, GL7 and GL9) were found in the human gastric antrum (Fig .
2). These cells showed a similar distribution and number to the cells identified by
antisera to gastrin-17 and gastrin-34 . However, the immunostaining was localized
predominantly to the perinuclear region of the G-cells, though it was not restricted
to it . Antisera PSN and gastrin-17 were found to detect reactive material in the same
(G) cells on semi-thin serial resin sections (Fig . 3) . Hyperplastic G-cells also showed
immunoreactivity to antisera PSN, GL7, GL9 and gastrin-34, but the density of
immunostaining was more than that in normal G-cells (Fig . 4) . At the ultrastructural
level in the normal antrum, gastrin-17 antiserum was found to react with both
immature (small [160-220 nm] spherical, electron-dense) and mature (large [240-
320 nm], spherical, pale-cored) secretory granules (Fig . 5), as previously described . 9
Similar results were obtained with antiserum PSN . However, in the highly active,
hyperplastic G-cells only minimal immunoreactivity to antiserum PSN was
observed .
In the duodenum, a few cells immunoreactive with the PSN, GL7 and GL9 antisera
were observed. These cells showed a similar number and distribution to those
demonstrated by the gastrin-34 antiserum ; however, this finding was in distinct
contrast to the large number of cells identified using the antiserum to gastrin-17,
some of which probably correspond to cholecystokinin-containing cells .
In foetal tissue, cells containing the C-flanking peptide of progastrin and C-
terminal gastrin were present in the duodenum from 8 weeks' gestation onwards
(Fig . 6). However, these cells were not seen in the stomach until 11 weeks of
gestation (Fig . 7). Immunostaining on serial sections demonstrated that C-terminal
gastrin (gastrin-17)-immunoreactive cells also contained PSN immunoreactivity at
all stages of development. However, in later foetuses (20-28 weeks) gastrin-17-
immunoreactive cells were seen more frequently than those immunostained with
the antiserum to PSN .
In the islet cell tumours producing gastrin, antisera PSN, GL7, GL9, gastrin-17 and
gastrin-34 revealed a similar, though variable, pattern of localization . In some cases
scattered cells were stained, in others solid blocks of tumour cells (Fig. 8, Fig . 4) . As in
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Fig. 2. Human antral mucosa containing scattered cells showing immunoreactivity for PSN. (a) Low 
magnification ( X 50) (with Nomarski optics). (b) Higher magnification ( x 200). 
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Fig. 3. Serial srtn-thin sections of resin-embedded human antrum lmmunostamed with antlsera (a) 
07, (b) PSN. The same cells can be seen in both sections and showing immunorractwity for the two 
portions of progastrin. Magnification X 300. 
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Fig. 4. Antral mucosa from a patient with pernicious anaemia showing large numbers of 
PSN-immunoreactive cells, some of which occur in abnormal clumps (arrows). Magnification x 170 
Fig. 5. Electron micrograph of PSN immunoreactwity in a normal C-cell from human gastric antrum. 
Immune-gold staining method using IO nm gold particles. The tissue is non-osmlcated. Magnification 
x 80,000 and (inset) x 200,000. 
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Fig. 6. Cells showing immunoreactivity for antiserum PSN in human duodenum at 8 weeks’ gestation 
Magnification X 250. 
the hyperplastic G-cells, at the electron microscopical level, minimal immuno- 
reactivity to antiserum PSN was obtained in C-cell tumours. 
DISCUSSION 
Alternative processing of genomic DNA nucleotide sequences can result in tissue- 
specific expression of primary transcripts, for example calcitonin in thyroid C-cells 
and calcitonin gene-related peptide (CCRP) in both central and peripheral nervous 
systems.‘9 However, there are many instances of multiple peptide sequences from 
single prohormones being expressed, synthesized and secreted by the same cells, 
for example calcitonin and katacalcin,20 glucagon and related peptides.*’ 
In this. study we have used three antisera (PSN, CL7 and CL9) raised against 
peptide fragments present in the C-terminal region of the human progastrin 
molecule. All three antisera detected gastrin-containing cells in human adult and 
foetal gastric antrum and duodenum, as well as in antral G-cell hyperplasia and 
pancreatic islet cell tumours producing gastrin (and associated with the Zollinger- 
Ellison syndrome). In the normal C-cells, PSN immunoreactivity was localized 
predominantly to the perinuclear region which would be consistent with the 
intracytoplasmic site of the Colgi complex. At the ultrastructural level, no peptide 
immunoreactivity was observed in association with the Colgi apparatus, but this 
may be the result of epitope masking by unknown factors, rather than reflecting a 
real absence of the PSN-containing antigen. 
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Fig. 7. ia) Haematoxyiin and eosin stained section of human foetal stomach of 11 weeks’ gestation. 
Magnification X 20. (b) Gastric mucosa from a human foetus at 11 weeks’ gestation containing scattered 
PSN-immunoreactive cells. Magnification X 300 (with Nomarski optics). 
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Fig. 8. PSN immunoreactivity in an islet ceil turnour from a patient with gastrinoma syndrome 
Magnification x 150 (with Nomarski optics). 
Castrin has a C-terminal octapeptide homology with another gut hormone, 
cholecystokinin (CCK), and because of this structural similarity the two peptides 
have often been difficult to differentiate by immunocytochemical techniques.** 
Although the C-flanking peptide of gastrin has a tetrapeptide N-terminal homology 
with the C-terminal flanking peptide of rat procholecystokinin (see Table I), light 
microscopical immunocytochemical observations would seem to suggest that CCK 
cells present in the duodenum are not detected by antiserum PSN. Thus it would 
appear that antiserum PSN is a reliable immunological marker for true duodenal 
gastrin cells at the light microscopical level. 
lmmunoreactivities for both gastrin and C-terminal progastrin were visualized in 
cells of the foetal human duodenum some weeks before they were seen in the 
gastric mucosa. The observation of G-cells appearing first in duodenum is in 
agreement with the results of other workers on both developing rat and human 
gut. 23~27 However, in this study gastrin was detected by immunocytochemistry at an 
earlier stage than has been reported previously. lmmunoreactive cells were first 
seen at 8 weeks in the duodenum and at 11 weeks in the antrum, in contrast to 10 
and 14 weeks, respectively, reported previously.‘“,” Although these results suggest 
that G-cells develop first in the duodenum of the human foetus it is possible that 
there are G-cells in the antrum also at the 8-weeks stage but containing too little 
peptide to be immunostained. Certainly it has been shown in foetuses of 10 weeks 
and above that the gastrin content of the duodenum, as measured by radioimmu- 
noassay, is up to 30 times that of the antrum. 
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The finding that, between 20 and 28 weeks of foetal life, relatively more cells show
immunoreactivity for G-17 rather than antiserum PSN is interesting and suggest that
progastrin may not be cleaved fully in developing cells . This may also be the case for
the gastrin-producing tumours where at the electron microscopical level, no
convincing reactivity with antiserum PSN was observed in neoplastic G-cells, which
was in striking contrast to the intense labelling associated with antral G-cell
secretory granules . These results may be compared with those recently reported by
Pauwels et al." who performed a radioimmunoassay and chromatographic study
using an antiserum recognizing the C-terminus of PSN on human gut and gastrin-
producing tumour extracts . They concluded that progastrin may not be processed
fully into smaller peptides in the tumour cells . Our findings thus provide circumstan-
tial support for the contention that progastrin does not undergo differential post-
transitional processing in transformed and perhaps also developing G-cells .
The reasons why progastrin is not cleaved fully to N-terminally extended gastrin
and free PSN peptides in neoplastic and developing cells have not been elucidated .
It may be that there is abnormal production, relatively low levels or suppression by
some means, of the enzyme responsible for gastrin-PSN cleavage. Abnormally high
levels of progastrin production, coupled with low enzyme concentrations could also
be conceived . Moreover, a recent report 29 has raised the possibility that human
progastrin may exist in two molecular forms, one phosphorylated . If progastrin
cleavage is dependent upon one or other molecular form being present this could
possibly account for the variability in immunostaining intensity. Thus our study
indicates that antisera specific for the C-flanking peptide of progastrin are useful in
distinguishing G-cells of the duodenum and for revealing variability in post-
translational processing of progastrin, as seen in developing, hyperplastic and
neoplastic G-cells .
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